CXXC5 and cancer: Finally, as discussed in detail previously combined targeting of different apoptosis-regulating pathways is a promising strategy in cancer treatment [33], and it may then be possible to design combinations that include RINF targeting but at the same time have acceptable hematological toxicity (33).